<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="127511">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01442246</url>
  </required_header>
  <id_info>
    <org_study_id>AFU-GETUG 20/0310</org_study_id>
    <nct_id>NCT01442246</nct_id>
  </id_info>
  <brief_title>Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.</brief_title>
  <official_title>Phase III Randomised Trial to Evaluate the Benefit of Adjuvant Hormonal Treatment With Leuprorelin Acetate (Eligard® 45 mg) for 24 Months After Radical Prostatectomy in Patients With High Risk of Recurrence.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UNICANCER</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>UNICANCER</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      PRINCIPAL OBJECTIVE: Evaluation of effectiveness in terms of survival without metastases to
      10 years, of adjuvant hormonal treatment with leuprorelin acetate (Eligard® 45 mg) for 24
      months after radical prostatectomy in patients with high risk of recurrence.

      SECONDARY OBJECTIVE(S):

        -  PSA evolution

        -  Evaluation of testosterone level

        -  Specific survival

        -  Overall survival

        -  Tolerance

        -  Quality of life (QLQ-C30 questionnaires)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The principal criterion is the evaluation of effectiveness in terms of survival without metastases to 10 years, of adjuvant treatment with leuprorelin acetate (Eligard® 45 mg) for 24 months after radical prostatectomy.</measure>
    <time_frame>The principal criterion will be evaluated 12 years after the inclusion of the first patient.</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Metastases</condition>
  <arm_group>
    <arm_group_label>Adjuvant treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Leuproreline acetate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surveillance</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Surveillance</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Leuprorelin Acetate</intervention_name>
    <description>Leuprorelin Acetate 45mg, one injection every 6 months for 24 months</description>
    <arm_group_label>Adjuvant treatment</arm_group_label>
    <other_name>Eligard®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients who have received the information leaflet and signed the consent form

          2. ≥ 18 years of age with a life expectancy of at least 10 years

          3. Performance Status (ECOG) ≤ 2

          4. Radical prostatectomy (RP) with or without extended pelvic lymphadenectomy in the 3
             months preceding inclusion

          5. Histologically confirmed prostatic adenocarcinoma 6.6. Patients R0, N0 or Nx or N+ (≤
             2 nodes among nodes removed), M0 and with at least one of the following criteria:

               -  postoperative Gleason score &gt; 7;

               -  postoperative Gleason score = 7 with the presence of high-grade Gleason patterns
                  (5);

               -  pT3b patients.

        7.Postoperative PSA &lt; 0.1 ng/mL (dosage perform within 2 months after surgery)
        8.Neutrophils ≥ 1500/mm3, platelets ≥ 100000/mm3 9.Bilirubin ≤ upper normal limit (this
        will not apply to subjects with Gilbert's syndrome, persistent or recurrent
        hyperbilirubinemia that is predominantly uncongugated in the absence of evidence of
        hemolysis or hepatic pathology); ASAT and ALAT ≤ 1.5 times upper normal limit; Creatinine
        &lt; 140 µmol/l (or clearance &gt; 60mL/min) 10.Patients affiliated to a social security scheme

        Exclusion Criteria:

          1. Previous treatments for prostatic adenocarcinoma (HT or orchyectomy or CT)

          2. Presence of metastases:

               -  positive bone scintigraphy, including Patients with medullary compression and/or

               -  abdominal-pelvic CT scan or MRI showing lymph node and/or visceral involvement.

          3. History of cancer, with the exception of basal cell carcinoma or any other cancer
             treated in the 5 years before inclusion and in complete remission.

          4. Incompatible concomitant treatment(s)

          5. Hypersensitivity to other GnRH agonists and/or any of the excipients of Eligard®

          6. Any illness or problem including geographic, psychiatric or psychological which is
             incompatible with being monitored during the trial

          7. Persons deprived of their freedom or under supervision (including guardianship),

          8. Patients already included in another therapeutic trial with an experimental drug or
             having been given an experimental drug within a period of 30 days.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François ROZET, MD</last_name>
    <role>Study Director</role>
    <affiliation>Montsouris Institute, Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephane Culine, Prof, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Saint-Louis Hospital, Paris, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>François ROZET, MD</last_name>
    <phone>00 33 1 56 61 66 21</phone>
    <email>françois.rozet@imm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stéphane CULINE, Prof MD</last_name>
    <phone>00 33 1 42 49 42 47</phone>
    <email>stephane.culine@sls.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinique Victor Pauchet</name>
      <address>
        <city>Amiens</city>
        <zip>80000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>VILLAMIZAR Jorge</last_name>
      <phone>03 22 33 71 16</phone>
      <email>jorge.villamizar@clinique-pauchet.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Besancon</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>KLEINCLAUSS François</last_name>
      <phone>03 81 21 88 85</phone>
      <email>francois.kleinclauss@univ-fcomte.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Bordeaux- Hopital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>ROBERT Grégoire</last_name>
      <phone>05 56 79 55 47</phone>
      <email>gregoire.robert@chu-bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Bergonie</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chru de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29069</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>FOURNIER Georges</last_name>
      <phone>02 98 34 71 70</phone>
      <email>georges.fournier@chu-brest.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>SALOMON Laurent</last_name>
      <phone>01 49 81 25 53</phone>
      <email>laurent.solomon@hmn.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Bocage</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CORMIER Luc</last_name>
      <phone>03 80 29 35 80</phone>
      <email>luc.cormier@chu-dijon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Departemental</name>
      <address>
        <city>La Roche Sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>GASCHINARD Nicolas</last_name>
      <phone>02 51 44 61 46</phone>
      <email>nicolas.gaschinard@wanadoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chru Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chu Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>DESCAZEAUD Aurélien</last_name>
      <phone>05 55 05 88 09</phone>
      <email>aurelien.descazeaud@chu-limoges.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Nord</name>
      <address>
        <city>Marseille</city>
        <zip>13015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique Beausoleil</name>
      <address>
        <city>Montpellier</city>
        <zip>34070</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>REBILLARD Xavier</last_name>
      <phone>04 67 75 97 70</phone>
      <email>xavier.rebillard@wanadoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Lapeyronie</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>THURET Rodolphe</last_name>
      <phone>06 82 39 64 69</phone>
      <email>rodolphethuret@yahoo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu de Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>ESCHWEGE Pascal</last_name>
      <phone>03 83 15 31 61</phone>
      <email>p.eschwege@chu-nancy.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chu Pasteur</name>
      <address>
        <city>Nice</city>
        <zip>06002</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>QUINTENS Hervé</last_name>
      <phone>04 92 03 77 87</phone>
      <email>quintens.h@orange.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Caremeau</name>
      <address>
        <city>Nimes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>DROUPY Stéphane</last_name>
      <phone>04 66 68 33 51</phone>
      <email>stephane.droupy@chu-nimes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Saint Louis</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MONGIAT-ARTUS Pierre</last_name>
      <phone>01 42 49 96 23</phone>
      <email>pierre.mongiat-artus@sls.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>PEYROMAURE Michael</last_name>
      <phone>01 58 41 41 41</phone>
      <email>michael.peyromaure@cch.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Mutualiste Montsouris</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ROZET François</last_name>
      <phone>01 56 61 66 20</phone>
      <email>francois.rozet@imm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HEGP</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MEJEAN Arnaud</last_name>
      <phone>01 56 09 54 02</phone>
      <email>arnaud.mejean@egp.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Tenon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CUSSENOT Olivier</last_name>
      <phone>01 56 01 64 95</phone>
      <email>olivier.cussenot@tnn.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Pitie Salpetriere</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>ROUPRET Morgan</last_name>
      <phone>06 60 54 41 66</phone>
      <email>mroupret@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu La Miletrie</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>IRANI Jacques</last_name>
      <phone>05 49 44 38 44</phone>
      <email>j.irani@chu-poitiers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Jean Godinot</name>
      <address>
        <city>Reims</city>
        <zip>51056</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>NGUYEN Tandat</last_name>
      <phone>03 26 50 43 51</phone>
      <email>tandatnguyen@reims.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hopsitalier Prive - Polyclinique Du Littoral</name>
      <address>
        <city>Saint Brieuc</city>
        <zip>22000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique Mutualiste</name>
      <address>
        <city>Saint Etienne</city>
        <zip>42013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chu Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67090</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopitaux Civils de Colmar</name>
      <address>
        <city>Strasbourg</city>
        <zip>68024</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>SCHNEIDER Marc</last_name>
      <phone>03 89 12 45 20</phone>
      <email>schneidermarc1@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>LEBRET Thierry</last_name>
      <phone>01 46 25 24 87</phone>
      <email>t.lebret@hopital-foch.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Rangueil</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SOULIE Michel</last_name>
      <phone>05 61 32 27 31</phone>
      <email>soulie.m@chu-toulouse.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <lastchanged_date>June 20, 2016</lastchanged_date>
  <firstreceived_date>September 27, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Benefit of</keyword>
  <keyword>adjuvant</keyword>
  <keyword>treatment</keyword>
  <keyword>prostatectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Leuprolide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
